Granules India informs about press release

13 Dec 2023 Evaluate

Granules India has informed that it enclosed the press release titled ‘Granules India Limited Received ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets’.

The above information is a part of company’s filings submitted to BSE.


Granules India Share Price

426.45 8.85 (2.12%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.